Global risk assessment for cardiovascular disease and astute clinical judgement

European Heart Journal

Volumn 24, Issue 21, 2003, Pages 1899-1900

  Hennekens, Charles H ^a,c   D'Agostino, Ralph B ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; STATIN;

CARDIOVASCULAR RISK; DYSLIPIDEMIA; EDITORIAL; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; GLUCOSE INTOLERANCE; HEALTH CARE POLICY; HEALTH SURVEY; HYPERTENSION; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICAL RESEARCH; OBESITY; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TREATMENT PLANNING;

CARDIOVASCULAR DISEASES; DECISION MAKING; HUMANS; RISK ASSESSMENT; RISK FACTORS;

EID: 0142240255     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.08.012     Document Type: Editorial

References (7)

1. Empana JP, Ducimetiere P, Arveiler D et al. Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations? The PRIME Study. Eur Heart J 2003;24:1903-11.
2. Wilson PWF, D'Agostino RB, Levy D et al. Prediction of coronary heart disease risk factor categories. Circulation 1998;97:1837-47.
3. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
4. Eidelman RS, Lamas GA, Hennekens CH. The new National Cholesterol Education Program guidelines: Clinical challenges for more wide-spread therapy of lipids to treat and prevent coronary heart disease. Arch Int Med 2002;162:2033-6.
5. D'Agostino RB, Grundy S, Sullivan LM et al. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic group investigation. JAMA 2001;286:180-7.
6. Marrugat J, D'Agostino R, Sullivan LM et al. An adaptation of the Framingham coronary heart disease risk function to European Mediterranean areas. J Epidemiol Commun Health 2003;57:634-8.
7. Hennekens CH. Clinical and research challenges in risk factors for cardiovascular diseases (The Geoffrey Rose Lecture at ESC). Eur Heart J 2000;21:1917-9.